Vicapsys Life Sciences, Inc.
Qualité des données : 83%
VICP
OTC
Manufacturing
Chemicals
1,46 €
0,00 €
(0,00%)
Cap. Boursière: 47,26 M
Prix
1,46 €
Cap. Boursière
47,26 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—
Quick Summary
Points Clés
Negative free cash flow of -125 741,0
Croissance
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Sécurité
Debt / Equity
N/A
Current Ratio0,03
Interest Coverage-14,65
Valorisation
PE (TTM)
-35,07
En dessous de la moyenne du secteur (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1385 pairs)
Comparaison Sectorielle
vs médiane du secteur Manufacturing (1385 pairs)| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -35,1 | -1,5 |
| P/B | — | 1,6 |
| ROE % | — | -54,0 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
Aucune estimation prévisionnelle disponible
No quarterly estimates available
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -1,35 M |
| ROE | N/A | ROA | -2085,47% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -125 741,0 |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,03 |
| Interest Coverage | -14,65 | Asset Turnover | N/A |
| Working Capital | -2,65 M | Tangible Book Value | -2,65 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -35,07 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -0,27% | ||
| Market Cap | 47,26 M | Enterprise Value | 47,17 M |
| Per Share | |||
| EPS (Diluted TTM) | -0,03 | Revenue / Share | N/A |
| FCF / Share | 0,00 | OCF / Share | 0,00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 9,33% |
| SBC-Adj. FCF | -146 438 | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Net Income | -1,18 M | -984 790,0 | -236 871,0 | -765 844,0 |
| EPS (Diluted) | -0,03 | — | — | — |
| Gross Profit | — | — | — | — |
| Operating Income | -1,05 M | -984 790,0 | -336 871,0 | — |
| EBITDA | — | — | — | — |
| R&D Expenses | 15 267,0 | 13 097,0 | 17 698,0 | 102 180,0 |
| SG&A Expenses | — | — | — | — |
| D&A | — | — | — | — |
| Interest Expense | 5 156,0 | — | — | — |
| Income Tax | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|
| Total Assets | 39 656,0 | 72 021,0 | 594 313,0 | 404 118,0 |
| Total Liabilities | — | — | — | — |
| Shareholders' Equity | -1,93 M | -950 791,0 | -121 651,0 | -449 106,0 |
| Total Debt | 18 712,0 | — | — | — |
| Cash & Equivalents | 9 422,0 | 14 097,0 | 217 295,0 | 1 269,0 |
| Current Assets | 39 656,0 | 72 021,0 | 222 793,0 | 1 269,0 |
| Current Liabilities | 1,97 M | 1,02 M | 715 964,0 | 853 224,0 |
{"event":"ticker_viewed","properties":{"ticker":"VICP","listing_kind":"stock","pathname":"/stocks/vicp","exchange":"OTC","country":"US"}}